DDR1 somatic mutation or gene amplification is not frequent in CRC (< 3% in cbioportal.org); however, transcriptomic analysis performed from 143 stage IV CRC patients CRC (Del Rio et al, 2017) reveals that a high level of DDR1 transcript is associated with a shorter relapse‐free and overall survival (Fig 7A). This evidence concerns the gene DDR1 and colorectal carcinoma.